ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,241Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 93

$651K Total Retail Price of All Prescriptions

Rank: 6 out of 93

780 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 780 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

9% of this provider’s 780 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,844 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 801 701 1 2
AMLODIPINE BESYLATE 726 643 2 6
LISINOPRIL 634 564 3 3
HYDROCHLOROTHIAZIDE 618 506 4 10
FUROSEMIDE 575 485 5 4
METFORMIN HCL 483 389 6 7
METOPROLOL SUCCINATE 440 391 7 14
METOPROLOL TARTRATE 376 311 8 11
OMEPRAZOLE 343 271 9 8
LOSARTAN POTASSIUM 326 282 10 26
HYDROCODONE-ACETAMINOPHEN 315 163 S3 11 9
LOVASTATIN 274 241 12 38
LEVOTHYROXINE SODIUM 272 246 13 5
ATENOLOL 270 262 14 16
WARFARIN SODIUM 245 182 15 12
CARVEDILOL 236 181 16 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 222 204 17 28
ENALAPRIL MALEATE 214 178 18 22
GABAPENTIN 212 174 19 17
HYDRALAZINE HCL 206 167 20 73
AMLODIPINE BESYLATE-BENAZEPRIL 206 189 20 53
IBUPROFEN 201 121 22 34
ALLOPURINOL 191 176 23 29
NIFEDIPINE ER 185 173 24 46
POTASSIUM CHLORIDE 178 109 25 13
TRIAMTERENE-HCTZ 168 155 26 29
VENTOLIN HFA 165 74 27 83
TAMSULOSIN HCL 160 148 28 24
GLIPIZIDE ER 141 131 29 56
CLONIDINE HCL 138 108 30 50
DOXAZOSIN MESYLATE 128 128 31 70
KLOR-CON M20 117 101 32 86
DIGOXIN 116 78 33 48
PRAVASTATIN SODIUM 116 97 33 20
LOSARTAN-HYDROCHLOROTHIAZIDE 115 96 35 75
GLYBURIDE-METFORMIN HCL 104 67 R 36 181
ATORVASTATIN CALCIUM 101 74 37 18
KLOR-CON 10 101 71 37 66
GLYBURIDE 94 90 R 39 47
DONEPEZIL HCL 94 94 39 25
GLIPIZIDE 93 72 41 41
FLUTICASONE PROPIONATE 91 47 42 90
ALENDRONATE SODIUM 90 90 43 39
TRAMADOL HCL 89 77 44 15
INSULIN SYRINGE 85 64 45 88
NIFEDIAC CC 85 82 45 194
RANITIDINE HCL 83 76 47 21
FINASTERIDE 78 75 48 134
OXYBUTYNIN CHLORIDE ER 77 75 49 78
CLOPIDOGREL 73 55 50 27
TRAMADOL HCL-ACETAMINOPHEN 71 57 51 215
DICLOFENAC SODIUM 70 56 52 170
AZITHROMYCIN 69 57 53 51
ZOLPIDEM TARTRATE 69 39 53 40
PANTOPRAZOLE SODIUM 68 43 55 36
SERTRALINE HCL 67 29 56 43
ADVAIR DISKUS 64 57 57 59
PREDNISONE 64 28 57 49
NEXIUM 64 50 57 33
SPIRONOLACTONE 63 43 60 67
AMITRIPTYLINE HCL 63 33 R 60 61
NIFEDICAL XL 61 54 62 138
GLIMEPIRIDE 61 49 62 60
BENAZEPRIL HCL 60 58 64 79
PROPRANOLOL HCL 58 52 65 93
DILTIAZEM ER 58 58 65 175
TRIAMCINOLONE ACETONIDE 56 33 67 140
MELOXICAM 55 52 68 42
ACETAMINOPHEN-CODEINE 54 28 S3 69 65
CYCLOBENZAPRINE HCL 53 28 R 70 71
LANSOPRAZOLE 53 38 70 118
FELODIPINE ER 52 52 72 107
FAMOTIDINE 52 28 72 32
PAROXETINE HCL 52 22 72 64
PLAVIX 52 40 72 44
COLCRYS 51 42 76 241
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.